Physician profile
Anna Park
NPI 1083260095
$4,122.90
in general payments reported to CMS, 2019-2025
20 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $589 · 2022: $706 · 2023: $700 · 2024: $1,038 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,827.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,748.41 | 2021-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $683.18 | 2021-2025 | |
| Novo Nordisk INC | $256.37 | 2023-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $247.21 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $205.80 | 2022-2024 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $168.47 | 2022 | |
| Sumitomo Pharma America, INC. | $129.78 | 2024-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $127.43 | 2023-2025 | Trelegy Ellipta |
| Pfizer INC. | $108.15 | 2022-2024 | |
| Aimmune Therapeutics, INC. | $61.67 | 2024-2025 | Zenpep |
| Amarin Pharma, INC. | $61.55 | 2021-2022 | |
| Astellas Pharma US INC | $53.30 | 2025 | Veozah |
| Vivus LLC | $44.23 | 2025 | Pancreaze |
| Allergan, INC. | $43.27 | 2021 | |
| Merck Sharp & Dohme LLC | $43.02 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $42.10 | 2025 | Zoryve |
| Ardelyx, INC. | $36.76 | 2024 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $24.82 | 2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $21.55 | 2022 | |
| Exact Sciences Corporation | $15.83 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.